Efficacy and Morbidity of Heparin Infusion in Salvaging Autologous Breast Reconstruction Free Flaps

IF 1.5 3区 医学 Q3 SURGERY
Microsurgery Pub Date : 2025-05-08 DOI:10.1002/micr.70065
Scott K. Odorico, Muhammad Sabry Mazroua, Leda Wang, Andrew Awadallah, Serena Day, Christin Harless, Jorys Martinez-Jorge, Aparna Vijayasekaran
{"title":"Efficacy and Morbidity of Heparin Infusion in Salvaging Autologous Breast Reconstruction Free Flaps","authors":"Scott K. Odorico,&nbsp;Muhammad Sabry Mazroua,&nbsp;Leda Wang,&nbsp;Andrew Awadallah,&nbsp;Serena Day,&nbsp;Christin Harless,&nbsp;Jorys Martinez-Jorge,&nbsp;Aparna Vijayasekaran","doi":"10.1002/micr.70065","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Abdominal-based free flaps are the mainstay in autologous breast reconstruction. Their safety and consistency in outcomes are well-documented. When flap compromise occurs, operative salvage is the gold standard. However, when—and if—to place these patients on heparin infusions is unclear. The goal of this study was to investigate abdominal-based free flap compromise and compare outcomes with and without heparin infusion.</p>\n </section>\n \n <section>\n \n <h3> Materials and Methods</h3>\n \n <p>This was a single-institution, multiple-surgeon, retrospective chart review of patients undergoing autologous, abdominal-based free flap breast reconstruction who experienced anastomotic compromise within a 6-year period. Treatment and outcomes data collected include flap salvage, hematoma, seroma, surgical site infection (SSI), transfusion requirement, and length of hospital stay.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Fifty-one flaps had evidence of compromise. A total of 31 (60.8%) patients were placed on heparin infusions after experiencing anastomotic compromise, compared to 20 who did not receive heparin infusion. Thirty-five patients (68.6%) underwent deep inferior epigastric perforator flaps. Twenty-six patients (51%) experienced venous congestion, 22 patients (43.1%) experienced arterial compromise, and three (5.9%) experienced both. Twenty-eight patients (54.9%) received tissue plasminogen activator; in the heparin infusion group, 21 patients (67.7%) received tissue plasminogen activator. The total salvage rate of compromised flaps was 94.1% (48/51). There was no significant difference between heparin infusion and standard cares in length of hospital stay, length of drains in-place, successful salvage (93.5% vs. 95%), hematoma (19.4% vs. 15%), fat necrosis, SSI, hospital readmission (19.4% vs. 15%), and return rates to the operating room (48.4% vs. 50%). However, there was a significantly higher transfusion rate in patients receiving heparin infusion (38.7% vs. 10%). Of the 25 flaps with evidence of thrombosis, 72% were placed on heparin infusions while 28% were not; there was no significant difference in salvage rate in this sub-group.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>This review of autologous breast reconstruction free flap compromise provides evidence of similar safety profiles, with similar salvage rates, when comparing salvage with and without heparin infusion; there is a higher transfusion requirement when treating with heparin infusion.</p>\n </section>\n </div>","PeriodicalId":18600,"journal":{"name":"Microsurgery","volume":"45 4","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microsurgery","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/micr.70065","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Abdominal-based free flaps are the mainstay in autologous breast reconstruction. Their safety and consistency in outcomes are well-documented. When flap compromise occurs, operative salvage is the gold standard. However, when—and if—to place these patients on heparin infusions is unclear. The goal of this study was to investigate abdominal-based free flap compromise and compare outcomes with and without heparin infusion.

Materials and Methods

This was a single-institution, multiple-surgeon, retrospective chart review of patients undergoing autologous, abdominal-based free flap breast reconstruction who experienced anastomotic compromise within a 6-year period. Treatment and outcomes data collected include flap salvage, hematoma, seroma, surgical site infection (SSI), transfusion requirement, and length of hospital stay.

Results

Fifty-one flaps had evidence of compromise. A total of 31 (60.8%) patients were placed on heparin infusions after experiencing anastomotic compromise, compared to 20 who did not receive heparin infusion. Thirty-five patients (68.6%) underwent deep inferior epigastric perforator flaps. Twenty-six patients (51%) experienced venous congestion, 22 patients (43.1%) experienced arterial compromise, and three (5.9%) experienced both. Twenty-eight patients (54.9%) received tissue plasminogen activator; in the heparin infusion group, 21 patients (67.7%) received tissue plasminogen activator. The total salvage rate of compromised flaps was 94.1% (48/51). There was no significant difference between heparin infusion and standard cares in length of hospital stay, length of drains in-place, successful salvage (93.5% vs. 95%), hematoma (19.4% vs. 15%), fat necrosis, SSI, hospital readmission (19.4% vs. 15%), and return rates to the operating room (48.4% vs. 50%). However, there was a significantly higher transfusion rate in patients receiving heparin infusion (38.7% vs. 10%). Of the 25 flaps with evidence of thrombosis, 72% were placed on heparin infusions while 28% were not; there was no significant difference in salvage rate in this sub-group.

Conclusions

This review of autologous breast reconstruction free flap compromise provides evidence of similar safety profiles, with similar salvage rates, when comparing salvage with and without heparin infusion; there is a higher transfusion requirement when treating with heparin infusion.

输注肝素抢救自体乳房重建游离皮瓣的疗效及发病率
背景腹部游离皮瓣是自体乳房重建术的主流。它们的安全性和结果的一致性是有据可查的。当皮瓣受损时,手术挽救是金标准。然而,何时以及是否给这些病人注射肝素还不清楚。本研究的目的是调查腹部自由皮瓣的损害,并比较输注肝素和不输注肝素的结果。材料和方法:本研究是一项单机构、多外科医生的回顾性研究,回顾了6年内吻合口受损的自体腹部自由皮瓣乳房重建术患者。收集的治疗和结局数据包括皮瓣保留、血肿、血肿、手术部位感染(SSI)、输血需求和住院时间。结果51个皮瓣有受损迹象。共有31例(60.8%)患者在吻合口受损后接受肝素输注,而20例患者未接受肝素输注。35例(68.6%)患者行深下腹壁穿支皮瓣。静脉充血26例(51%),动脉受累22例(43.1%),两者兼有3例(5.9%)。28例(54.9%)患者接受组织型纤溶酶原激活剂;肝素输注组21例(67.7%)患者使用组织型纤溶酶原激活剂。受损皮瓣的总抢救率为94.1%(48/51)。肝素输注与标准护理在住院时间、引流管放置时间、抢救成功(93.5% vs 95%)、血肿(19.4% vs 15%)、脂肪坏死、SSI、再入院(19.4% vs 15%)和返回手术室率(48.4% vs 50%)方面无显著差异。然而,接受肝素输注的患者输血率明显更高(38.7% vs. 10%)。在25个有血栓形成证据的皮瓣中,72%给予肝素输注,28%未给予肝素输注;两组间抢救率无显著性差异。结论:本综述对自体乳房重建游离皮瓣妥协提供了相似的安全性和相似的挽回率的证据,与肝素输注和不输注的挽回率相比;肝素输注治疗时输血需要量较高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Microsurgery
Microsurgery 医学-外科
CiteScore
3.80
自引率
19.00%
发文量
128
审稿时长
4-8 weeks
期刊介绍: Microsurgery is an international and interdisciplinary publication of original contributions concerning surgery under microscopic magnification. Microsurgery publishes clinical studies, research papers, invited articles, relevant reviews, and other scholarly works from all related fields including orthopaedic surgery, otolaryngology, pediatric surgery, plastic surgery, urology, and vascular surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信